Finally, this review highlights CRP’s role in destabilizing vascular tissue via immune signaling, smooth muscle cell activation, and endothelial dysfunction, linking chronic low-grade inflammation to increased arterial vulnerability and eventually plaque instability, especially in patients with diabetes or metabolic syndrome. This evidence concerns the gene CRP and metabolic syndrome.